Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04927897

DETECT: Target Volume for Rectal Endoluminal Radiation Boosting

DETECT: Defining the Target Volume for Endoluminal Radiation Boosting in Patients With Rectal Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Maastricht Radiation Oncology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to provide prospective data regarding microscopic tumor spread in all directions from the macroscopic tumor in pathology specimens, as seen by eye, and on imaging to define the target volume for endoluminal radiation boosting in rectal cancer patients.

Detailed description

This study is a prospective multicentre cohort trial in ≥50 patients with a residual ycT1-3N0 tumor after neoadjuvant chemoradiotherapy or radiotherapy for rectal adenocarcinoma at least 6 weeks after the neoadjuvant treatment. In addition to standard workup and treatment (e.g. a flexible endoscopy and an MRI scan at 6-8 weeks post-neoadjuvant therapy), patients will undergo pre-operatively, after induction of general anaesthesia, an endorectal ultrasound and rigid rectoscopy as study procedures if these procedures are not already part of standard workup. Furthermore, the pathological specimens of some patients will be scanned using MR imaging during certain parts of the pathological process. Objectives include determining the maximum distance of microscopic tumor spread per patient in all directions, creating a tissue deformation model to account for changes due to e.g. fixation and pathological processing, using this tissue deformation model to translate the microscopic tumor spread back to the in vivo situation (e.g. back to in vivo MRI scans, 3D endo-ultrasounds), and evaluating/determining risk factors for the presence and/or extent of microscopic tumor spread. This data will be used for target volume definition in rectal endoluminal radiation boosting.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUltrasound3D endorectal ultrasound.
DIAGNOSTIC_TESTRectoscopyRigid rectoscopy.
OTHERScan, e.g. CT (resection specimen)For some patients, images of the resection specimen (note: NOT of the patients) during the pathological process will be acquired.

Timeline

Start date
2022-08-16
Primary completion
2027-05-01
Completion
2027-12-01
First posted
2021-06-16
Last updated
2025-07-28

Locations

3 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04927897. Inclusion in this directory is not an endorsement.